|
|
Special News Report
La Jolla, California--Tobacco companies are a major source of support for academic biomedical research in the United States, and these funds are growing. A major debate is brewing in the community over this form of funding, however. Many researchers argue that as long as the funds are provided by peer review and the recipients are entirely free to conduct and publish their research, tobacco money can provide a key source of support for important work at a time when traditional funds are scarce. Critics charge, however, that the industry uses the fact that it is supporting prominent researchers to sow doubts about the health hazards of smoking.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)
Magazine | News | Signaling | Careers | Multimedia | Collections | Help | Site Map | RSS
Subscribe | Feedback | Privacy / Legal | About Us | Advertise With Us | Contact Us
© 1996 American Association for the Advancement of Science. All Rights Reserved.
AAAS is a partner of HINARI, AGORA, PatientInform, CrossRef, and COUNTER.
You have reached the bottom of the page. Back to top